Cardiovascular risk assessment in South and Middle-East Asians living in the Western countries.
Cardiovascular risk
Caucasians
Diabetes
Hypertension
Metabolic Syndrome
Middle-East
South Asians
Journal
Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117
Informations de publication
Date de publication:
Historique:
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
26
11
2020
Statut:
ppublish
Résumé
Nearly a quarter of the world population lives in the South Asian region (India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, and the Maldives). Due to rapid demographic and epidemiological transition in these countries, the burden of non-communicable diseases is growing, which is a serious public health concern. Particularly, the prevalence of pre-diabetes, diabetes and atherosclerotic cardiovascular disease (CVD) is increasing. South Asians living in the West have also substantially higher risk of CVD and mortality compared with white Europeans and Americans. Further, as a result of global displacement over the past three decades, Middle-Eastern immigrants now represent the largest group of non-European immigrants in Northern Europe. This vulnerable population has been less studied. Hence, the aim of the present review was to address cardiovascular risk assessment in South Asians (primarily people from India, Pakistan and Bangladesh), and Middle-East Asians living in Western countries compared with whites (Caucasians) and present results from some major intervention studies. A systematic search was conducted in PubMed to identify major cardiovascular health studies of South Asian and Middle-Eastern populations living in the West, relevant for this review. Results indicated an increased risk of CVD. In conclusion, both South Asian and Middle-Eastern populations living in the West carry significantly higher risk of diabetes and CVD compared with native white Europeans. Lifestyle interventions have been shown to have beneficial effects in terms of reduction in the risk of diabetes by increasing insulin sensitivity, weight loss as well as better glycemic and lipid control.
Identifiants
pubmed: 33235604
doi: 10.12669/pjms.36.7.3292
pii: PJMS-36-1719
pmc: PMC7674869
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1719-1725Subventions
Organisme : NHLBI NIH HHS
ID : K24 HL112827
Pays : United States
Informations de copyright
Copyright: © Pakistan Journal of Medical Sciences.
Déclaration de conflit d'intérêts
Conflict of Interest: None.
Références
Diabetologia. 2020 Jun;63(6):1103-1109
pubmed: 32236731
Circulation. 2018 Jul 3;138(1):e1-e34
pubmed: 29794080
Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):229-34
pubmed: 19276982
BMJ Open. 2019 Oct 19;9(10):e028076
pubmed: 31630098
J Public Health (Oxf). 2007 Jun;29(2):191-8
pubmed: 17456532
J Am Coll Cardiol. 2016 May 10;67(18):2118-2130
pubmed: 27151343
J Hum Hypertens. 2020 Mar;34(3):207-213
pubmed: 30647462
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
Diabetes Care. 2014 Sep;37(9):2500-7
pubmed: 24974975
Am Heart J. 2011 Sep;162(3):460-6
pubmed: 21884861
Open Heart. 2018 Jul 11;5(2):e000821
pubmed: 30018780
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Res Clin Pract. 2008 Jan;79(1):147-50
pubmed: 17767973
Diabetes Care. 2004 May;27(5):1047-53
pubmed: 15111519
Circulation. 2001 Dec 4;104(23):2855-64
pubmed: 11733407
J Immigr Minor Health. 2011 Feb;13(1):101-10
pubmed: 19779820
J Am Heart Assoc. 2019 Jul 16;8(14):e011874
pubmed: 31291803
Hypertension. 1993 Jul;22(1):90-6
pubmed: 8319998
Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):46-51
pubmed: 15703505
Lancet. 2020 Mar 7;395(10226):795-808
pubmed: 31492503
Eur J Public Health. 2019 Oct 1;29(5):888-894
pubmed: 30809646
Global Health. 2019 May 2;15(1):33
pubmed: 31046779
BMC Public Health. 2016 Dec 9;16(1):1242
pubmed: 27938404
PLoS One. 2013 Jul 22;8(7):e68605
pubmed: 23894322
Diabetes Care. 2014 Jun;37(6):1621-8
pubmed: 24705613
J Hypertens. 2013 Aug;31(8):1517-26
pubmed: 23743805
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Br J Nutr. 2013 Feb 14;109(3):529-38
pubmed: 22717286
CMAJ. 2002 Mar 19;166(6):717-22
pubmed: 11944758
Am J Cardiovasc Dis. 2011;1(1):31-7
pubmed: 22254183
Prev Med. 2017 Mar;96:79-84
pubmed: 28007496
BMC Public Health. 2015 Oct 20;15:1073
pubmed: 26487492
BMJ Open. 2017 Dec 6;7(12):e016819
pubmed: 29217719
Lancet Diabetes Endocrinol. 2016 Jun;4(6):517-24
pubmed: 27131930
Int J Prev Med. 2010 Winter;1(1):19-28
pubmed: 21677762
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
Heart. 2014 Jan;100(1):60-7
pubmed: 24186564
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
Diabetes Metab Syndr Obes. 2014 May 02;7:139-44
pubmed: 24833912
Int J Behav Nutr Phys Act. 2012 Apr 26;9:47
pubmed: 22537281
Eur J Prev Cardiol. 2013 Dec;20(6):1013-21
pubmed: 22642981
Lancet Diabetes Endocrinol. 2014 Mar;2(3):218-27
pubmed: 24622752
Eur J Prev Cardiol. 2015 Oct;22(10):1261-71
pubmed: 24942224
Diabetologia. 1991 Dec;34(12):891-8
pubmed: 1778354
Atherosclerosis. 2014 May;234(1):102-7
pubmed: 24632509
Indian Heart J. 1996 Jul-Aug;48(4):343-53
pubmed: 8908818
Eur J Prev Cardiol. 2015 Oct;22(10):1281-9
pubmed: 25261269
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Metabolism. 2017 Jan;66:1-13
pubmed: 27923444
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
Atherosclerosis. 2006 Apr;185(2):297-306
pubmed: 16005463
Eur Heart J. 2010 Mar;31(5):588-94
pubmed: 19933282
J Hypertens. 2014 Dec;32(12):2362-70; discussion 2370
pubmed: 25255394
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
Lancet Glob Health. 2020 Apr;8(4):e511-e523
pubmed: 32199120
Int J Public Health. 2016 Jun;61(5):525-34
pubmed: 26361963
Heart. 2010 Mar;96(6):466-71
pubmed: 19578033
BMJ. 1999 Jul 24;319(7204):215-20
pubmed: 10417082
Int J Obes (Lond). 2006 Apr;30(4):684-90
pubmed: 16130029
Ann Intern Med. 2013 Oct 15;159(8):543-51
pubmed: 24126648
Int J Environ Res Public Health. 2018 Feb 27;15(3):
pubmed: 29495529
Metab Syndr Relat Disord. 2010 Apr;8(2):157-64
pubmed: 19943798